🇺🇸 FDA

Company profile · Sponsor

The

The University of Hong Kong

C190F02 · NMPA pharma CN
Pipeline
24
Drugs
0
Patents
0

Quick answer

The (C190F02) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C190F02
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (24)

Search pipeline →

  1. 25% AgNO3 solution followed by 5% NaF

    The

    Early Childhood Caries

    phase 3 small molecule completed

    1 trial

  2. 3-second SDF application

    The

    Early Childhood Caries

    phase 3 other completed

    1 trial

  3. Acupuncture (Procedure)

    The

    Autistic Disorder

    phase 3 other completed

    1 trial

  4. Masticatory muscle training exerciser

    The

    Mastication

    phase 3 other active

    1 trial

  5. SDF solution

    The

    Dental Caries

    phase 3 other completed

    1 trial

  6. Vortioxetine

    The

    Cannabis Use Disorder

    phase 3 small molecule completed

    1 trial

  7. Atezolizumab

    The

    NSCLC Stage IIIB

    phase 2 small molecule active

    1 trial

  8. Bomedemstat

    The

    Myelofibrosis

    phase 2 small molecule active

    1 trial

  9. Capecitabine

    The

    Pancreatic Adenocarcinoma

    phase 2 small molecule completed

    1 trial

  10. Dapagliflozin 10mg Tab

    The

    Lupus Nephritis

    phase 2 small molecule active

    1 trial

  11. Decitabine

    The

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  12. Dietary

    The

    Colorectal Cancer

    phase 2 other active

    1 trial

  13. Interferon Beta-1B

    The

    COVID

    phase 2 small molecule completed

    1 trial

  14. Oral arsenic trioxide

    The

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  15. Traditional Chinese acupuncture

    The

    Phonotraumatic Injuries

    phase 2 other active

    1 trial

  16. pembrolizumab

    The

    T-Cell Lymphoma

    phase 2 small molecule active

    1 trial

  17. Folic Acid 5 MG

    The

    Acute Kidney Injury

    phase 1 small molecule active

    1 trial

  18. Alcohol injection

    The

    Malignancy

    approved small molecule active

    1 trial

  19. Atosiban

    The

    Subfertility

    approved small molecule completed

    1 trial

  20. Brolucizumab

    The

    Age-Related Macular Degeneration

    approved small molecule completed

    1 trial

  21. Bupivacaine Injection [Marcaine]

    The

    Acute Pain

    approved small molecule completed

    1 trial

  22. Cinacalcet

    The

    Kidney Failure

    approved small molecule completed

    1 trial

  23. Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy

    The

    Fontan

    approved small molecule active

    1 trial

  24. Dexamethasone

    The

    Total Knee Replacement

    approved small molecule active

    1 trial

Frequently asked questions

What is The?

The (C190F02) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does The sponsor?

We track 24 ClinicalTrials.gov-linked programs for The, including 25% AgNO3 solution followed by 5% NaF and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does The company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.